Reexamination of Patient Autonomy and Prior Therapies in Oncology Clinical Trial Eligibility Criteria Reply

被引:0
|
作者
Hope, Thomas A. [1 ,2 ,3 ]
Calais, Jeremie [4 ,5 ]
机构
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 185 Berry St,Ste 350, San Francisco, CA 94107 USA
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[3] San Francisco VA Med Ctr, Dept Radiol & Biomed Imaging, San Francisco, CA USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Translat Theranost Div, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[5] Univ Duisburg Essen, German Canc Consortium DKTK, Dept Nucl Med, Univ Hosp Essen, Essen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Broadening Eligibility Criteria for Oncology Clinical Trials: Current Advances and Future Directions
    Rahman, Nam Atiqur
    Ison, Gwynn
    Beaver, Julia A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 419 - 421
  • [32] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group
    Uldrick, Thomas S.
    Ison, Gwynn
    Rudek, Michelle A.
    Noy, Ariela
    Schwartz, Karl
    Bruinooge, Suanna
    Schenkel, Caroline
    Miller, Barry
    Dunleavy, Kieron
    Wang, Judy
    Zeldis, Jerome
    Little, Richard F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (33) : 3774 - 3780
  • [33] Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients
    Yizhao Ni
    Jordan Wright
    John Perentesis
    Todd Lingren
    Louise Deleger
    Megan Kaiser
    Isaac Kohane
    Imre Solti
    BMC Medical Informatics and Decision Making, 15
  • [34] Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients
    Ni, Yizhao
    Wright, Jordan
    Perentesis, John
    Lingren, Todd
    Deleger, Louise
    Kaiser, Megan
    Kohane, Isaac
    Solti, Imre
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2015, 15
  • [35] DIFFERENCES IN ELIGIBILITY CRITERIA AND BASELINE PATIENT CHARACTERISTICS AMONGST TRIALS OF BIOLOGIC THERAPIES IN ASTHMA
    Bacharier, L.
    Casale, T.
    Holden, M.
    Rajput, Y.
    Dang, J.
    Li, Q.
    Herrera-Restrepo, O.
    Bilir, P.
    Karabis, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S45 - S46
  • [36] Drivers of Clinical Trial Participation-Demographics, Disparities, and Eligibility Criteria
    Mishkin, Grace
    Arnaldez, Fernanda
    Ivy, S. Percy
    JAMA ONCOLOGY, 2019, 5 (03) : 305 - 306
  • [37] Are select demographic groups being excluded by clinical trial eligibility criteria?
    Yoder, Katelyn
    Muller, Carolyn
    Hill, Deirdre
    Griego, Marisa
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : E38 - E38
  • [38] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group
    Lin, Nancy U.
    Prowell, Tatiana
    Tan, Antoinette R.
    Kozak, Marina
    Rosen, Oliver
    Amiri-Kordestani, Laleh
    White, Julia
    Sul, Joohee
    Perkins, Louise
    Beal, Katherine
    Gaynor, Richard
    Kim, Edward S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (33) : 3760 - 3773
  • [39] Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship
    Ruiz, Jenny
    Kelly, Rebecca K.
    Aplenc, Richard
    Laetsch, Theodore W.
    Seif, Alix E.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (05)
  • [40] Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials.
    Bhandari, Sudip
    Mann, Jeremy
    Chawla, Jitesh
    Jain, Prerna
    Knight, Margot
    Lagor, Charles
    Mueller, Judith
    Raska, Paola
    Southwick, Steve
    Whyte, Warren
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18701 - E18701